The best online providers offer strong support services to help you succeed in your GLP-1 weight loss journey.

There has been a lot of excitement since the launch. Not only is the drug extremely effective (people lose about 15 percent ...

Knee cartilage is not designed for high stress loads. People who are overweight or obese are at a higher risk of developing osteoarthritis because of the extra stress on their knee joints, with many ...

The weight-loss jab Wegovy made its debut on June 4 2021 . It was the first new weight-loss drug to be approved by the US Food and Drug ...

Compounded semaglutide: Medication produced by compounded pharmacies instead of the original drug manufacturer (Novo Nordisk, ...

and the US [for semaglutide]. We may not be the first wave launcher in the US, but we have plans." Natco and Mylan have also ...

The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move could jeopardize the availability of cheaper, generic forms of those drugs ...

FDA has not approved any generic versions of semaglutide." Eli Lilly, makers of Mounjaro and Zepbound, also used for weight loss, told CBS News: "Lilly has taken steps to help inform people about the ...

tirzepatide and semaglutide. Both drugmakers have filed several lawsuits against compounding pharmacies, medical spas, clinics and other drug companies for allegedly selling unsafe copycat versions; ...

Drugmaker Lupin aims to be part of the first wave of generic drugmakers to make GLP-1 receptor agonists products, used to ...